Fundraising
Rakuten Medical
Rakuten Medical Raises $100M Series F | Photoimmunotherapy Cancer Treatment
San Diego, CAJanuary 8, 20261 min read
Total Raised
$100M
Latest Round
Series F
Employees
200+
Rakuten Medical Closes $100M for Cancer Treatment
Rakuten Medical, developing photoimmunotherapy treatments for cancer, has raised $100 million in Series F funding led by TaiAx.
Key Highlights
- Currently in global Phase 3 trial
- Novel photoimmunotherapy approach
- Late-stage clinical development
Company Overview
Rakuten Medical is developing a precision cancer treatment using photoimmunotherapy that selectively destroys cancer cells while preserving healthy tissue.
Company Info
Headquarters
San Diego, CA
Team Size
200+
Last Round
$100M(Jan 2026)
Investors (2)
T
TaiAxLeadLead Investor
Healthcare investment firm
R
RakutenStrategic Investor
Japanese technology conglomerate
Share
Related Reports
Fundraising
Tebra
Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform
Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.
SalesTools Research
Jan 12, 2026
0 min readβ’$250M
Fundraising
Harmattan AI
Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation
French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.
SalesTools Research
Jan 11, 2026
0 min readβ’$200M
Fundraising
AirNexis Therapeutics
AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment
Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.
SalesTools Research
Jan 11, 2026
0 min readβ’$200M
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free